KDM5A and KDM5B induces the growth of cancer cells, reduces the expression of tumor suppressor genes, facilitates the acquired tolerance of cancer-fighting drugs, and maintains tumor-initiating cells [198]. The gene discussed is KDM5A; the disease is cancer.